Relief Therapeutics Holding AG (RLFTF)

[DonDonDonDon]

Any doctor will want zyesami. It worked better than the standard of care. Plus decrease hospitalisation by 10 days!

It didn't decrease hospitalization by 10 days. You can't say that as a blanket statement. It decreased hospitalization by 10 days for one subgroup and we don't even know how big that group was. When you have a tiny study, 195 patients, and further divide it into subgroups, you'll have some random good effects for some of the groups at some points. That is the law of probabilities. Also, it didn't work better than the standard of care. The mortality rate was higher in the treatment arm. So the study failed its primary endpoint and the secondary endpoint of mortality. I'm sure that RLFTF is praying that the mortality rate evens out at 60 days. But it is solely a hope. If you rewatch Dr Javitt in the Dr Yo interview, he starts breathing really heavy and almost starts crying when he explains the mortality data. It is obvious that the trial was a complete disappointment to him as he is forced into the lie that the mortality data will be better at day 60. Here is the video, go to the 6:30 point to see when he gets super emotional: